Correction to "Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing"

No authors listed

Published Erratum

No authors listed. Clin Pharmacol Ther. 2025 Sep.

. 2025 Sep;118(3):744-745.

doi: 10.1002/cpt.3755. Epub 2025 Jun 29.

No abstract available

Erratum for

Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing.
Garcia-Cremades M, Solans BP, Hughes E, Ernest JP, Wallender E, Aweeka F, Luetkemeyer AF, Savic RM. Garcia-Cremades M, et al. Clin Pharmacol Ther. 2020 Aug;108(2):253-263. doi: 10.1002/cpt.1856. Epub 2020 May 12. Clin Pharmacol Ther. 2020. PMID: 32285930 Free PMC article.

1. Gautret, P. et al. RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. Int. J. Antimicrob. Agents 56, 105949 (2020). - PMC - PubMed
1. Garcia‐Cremades, M. et al. Optimizing hydroxychloroquine dosing for patients with COVID‐19: an integrative modeling approach for effective drug repurposing. Clin. Pharmacol. Ther. 108(2), 253–263 (2020). - PMC - PubMed
1. Cavalcanti, A.B. et al. Hydroxychloroquine with or without Azithromycin in mild‐to‐moderate covid‐19. N. Engl. J. Med. 383(21), 2041–2052 (2020). - PMC - PubMed
1. Farré, N. et al. Prolonged QT Interval in SARS‐CoV‐2 infection: prevalence and prognosis. J. Clin. Med. 9(9), 2712 (2020). - PMC - PubMed
1. Merino, J.L. , Martínez‐Cossiani, M. , Iniesta, A. , Escobar, C. , Rey, J.R. & Castrejón‐Castrejón, S. COVID‐19 and QT interval prolongation: more than just drug toxicity? EP Europace 22(10), 1479 (2020). - PMC - PubMed